Moderna said Tuesday that its updated COVID-19 vaccine demonstrated a stronger immune response than its current jab in ...
Moderna Inc (NASDAQ:MRNA) said that mRNA-1283, the company’s next-generation COVID-19 vaccine, has met the primary endpoints ...